NCT02806102

CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction II (COREA-AMI II)

Cardiovascular Risk and Identification of Potential High-risk Population in Korean Patients With Acute Myocardial Infarction II (COREA-AMI II)

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 13,000 (estimated)
• Sponsor: Seoul St. Mary's Hospital · Academic / Other
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

This study is intended to provide contemporary data on the residual cardiovascular risk in all consecutive patients with acute myocardial infarction, especially in patients who survived stably within one-year after percutaneous coronary intervention. In addition, this study will identify which baseline clinical, angiographic, or treatment factors are associated with residual cardiovascular risk and bleeding events

Detailed description

COREA-AMI registry was conducted previously (NCT02385682) and enrolled consecutive all patient with acute myocardial infarction who were treated with percutaneous coronary intervention from Jan 2004 to Dec 2009. COREA-AMI II registry extend the enrollment period to Aug 2014 and the follow-up period to Jun 2016. All consecutive acute myocardial infarction patients had been enrolled prospectively in prior registries of each university hospitals. Eight hospitals of the Catholic University of Korea already have web-based coronary intervention registry (NCT01239914). And Cheonnam University Hospital is one of leading hospitals to design and manage the web-based previous Korean nationwide myocardial infarction registry, the Korea Acute Myocardial Infarction Registry (KAMIR) (http://www.kamir.or.kr/). Using these previous data, the current registry update new clinical and angiographic variables and assess long-term clinical follow-up data retrospectively. All data were collected on web-based system after eliminating personal information. (http://www.ecrf.kr/coreaami/) All data are going to be sealed with code by Clinical Research Coordinating Center of the Catholic University of Korea and to be managed and analyzed by independent statistics perssonels. Cardiovascular center with high-volume percutaneous coronary intervention of following hospitals were participated. * Seoul St. Mary's Hospital, Seoul, South Korea * Yeoido St. Mary's Hospital, Seoul, South Korea * Uijongbu St. Mary's Hospital, Gyeonggi-do, South Korea * St. Paul Hospital, Seoul, South Korea * Bucheon St. Mary's Hospital, Gyeonggi-do, South Korea * Incheon St. Mary's Hospital, Incheon, South Korea * St. Vincent Hospital, Gyeonggi-do, South Korea * Deajon St. Mary's Hospital, Daejeon, South Korea * Cheonnam University Hospital, Gwangju, South Korea

Conditions

• Acute Myocardial Infarction
• Percutaneous Coronary Intervention
• Major Adverse Cardiovascular Events
• Bleeding

Interventions

Type	Name	Description
PROCEDURE	Percutaneous coronary intervention	Percutaneous coronary intervention
DRUG	Dual-antiplatelet therapy	Dual AntiPlatelet Therapy
PROCEDURE	Percutaneous coronary intervention	Percutaneous coronary intervention
DRUG	Dual-antiplatelet therapy	Dual AntiPlatelet Therapy

Timeline

• Start date: 2004-01-01
• Primary completion: 2017-02-01
• Completion: 2018-02-01
• First posted: 2016-06-20
• Last updated: 2016-07-06

Locations

2 sites across 1 country: South Korea